New treatments for neuropathic pain
- PMID: 16409165
- DOI: 10.1146/annurev.med.57.121304.131324
New treatments for neuropathic pain
Abstract
Existing treatments for neuropathic pain deliver inadequate pain relief, unacceptable side effects, or both. The unmet medical need for more effective treatment is driving a large volume of research to discover new drugs. Most existing treatments are drugs introduced to treat other pain conditions or other medical conditions, such as antidepressants and anticonvulsants, which were found empirically to be effective for neuropathic pain. Only recently have drug discovery efforts have become mechanistically driven, addressing targets identified by a molecular neurobiological approach to the pathophysiology of neuropathic states.
Similar articles
-
Elucidation of pathophysiology and treatment of neuropathic pain.Cent Nerv Syst Agents Med Chem. 2012 Dec;12(4):304-14. doi: 10.2174/187152412803760645. Cent Nerv Syst Agents Med Chem. 2012. PMID: 23033930 Review.
-
[Mechanisms of the development of neuropathic pain and its treatment].Nihon Hansenbyo Gakkai Zasshi. 2008 Sep;77(3):215-8. doi: 10.5025/hansen.77.215. Nihon Hansenbyo Gakkai Zasshi. 2008. PMID: 18800643 Review. Japanese.
-
Management of severe neuropathic cancer pain: an illustrative case and review.Am J Hosp Palliat Care. 2013 Feb;30(1):83-90. doi: 10.1177/1049909112443586. Epub 2012 Apr 13. Am J Hosp Palliat Care. 2013. PMID: 22504863 Review.
-
Pharmacological treatments of neuropathic pain: The latest recommendations.Rev Neurol (Paris). 2019 Jan-Feb;175(1-2):46-50. doi: 10.1016/j.neurol.2018.08.005. Epub 2018 Oct 11. Rev Neurol (Paris). 2019. PMID: 30318260 Review.
-
Novel sodium channel antagonists in the treatment of neuropathic pain.Expert Opin Investig Drugs. 2016;25(2):215-26. doi: 10.1517/13543784.2016.1121992. Epub 2015 Dec 14. Expert Opin Investig Drugs. 2016. PMID: 26576738 Review.
Cited by
-
Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent NaV1.7 inhibitors.Medchemcomm. 2016 Dec 2;8(4):744-754. doi: 10.1039/c6md00578k. eCollection 2017 Apr 1. Medchemcomm. 2016. PMID: 30108793 Free PMC article.
-
Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research.Front Pharmacol. 2021 Feb 8;11:614990. doi: 10.3389/fphar.2020.614990. eCollection 2020. Front Pharmacol. 2021. PMID: 33628181 Free PMC article. Review.
-
Antinociceptive Effect of Cyperi rhizoma and Corydalis tuber Extracts on Neuropathic Pain in Rats.Korean J Physiol Pharmacol. 2012 Dec;16(6):387-92. doi: 10.4196/kjpp.2012.16.6.387. Epub 2012 Dec 10. Korean J Physiol Pharmacol. 2012. PMID: 23269900 Free PMC article.
-
Blockade of PDGFR-β activation eliminates morphine analgesic tolerance.Nat Med. 2012 Feb 19;18(3):385-7. doi: 10.1038/nm.2633. Nat Med. 2012. PMID: 22344297 Free PMC article.
-
Predictive validity of behavioural animal models for chronic pain.Br J Pharmacol. 2011 Oct;164(4):1195-206. doi: 10.1111/j.1476-5381.2011.01300.x. Br J Pharmacol. 2011. PMID: 21371010 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources